Search Trials
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy – ACE Inhibitor Therapy Trial
Status:
Completed
Last Changed:
May 4, 2015
First Changed:
May 4, 2015
Disease(s):
Myocardial Fibrosis
Intervention(s):
Enalapril
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
Status:
Terminated
Last Changed:
Jan 14, 2020
First Changed:
Jan 12, 2016
Disease(s):
Muscular Dystrophy
Intervention(s):
Tadalafil 20 MGbeetroot juice extract
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Status:
Completed
Last Changed:
Feb 3, 2016
First Changed:
Aug 13, 2013
Disease(s):
Other Diseases or Conditions
Intervention(s):
sleep parametersHormonal profileInflammatory profileCardiovascular profileMetabolic profile
NasoShield Study of Safety and Immunogenicity
Status:
Unknown status
Last Changed:
Nov 29, 2018
First Changed:
Nov 24, 2017
Disease(s):
Healthy Volunteers
Intervention(s):
NasoShieldBioThraxPlacebo
Clinical Benefit, Safety and PK of Raxibacumab in Subjects Exposed to Bacillus Anthracis
Status:
Not yet recruiting
Last Changed:
Oct 5, 2020
First Changed:
Jun 30, 2014
Disease(s):
Infections, Bacterial
Intervention(s):
Collection of samples
Ph1 Study of Valortim and Ciprofloxacin in Humans
Status:
Suspended
Last Changed:
Aug 10, 2010
First Changed:
Aug 25, 2009
Disease(s):
Anthrax
Intervention(s):
Ciprofloxacin and ValortimPlacebo Antibiotic and ValortimPlacebo Antibiotic and Placebo Valortim
An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis
Status:
Not yet recruiting
Last Changed:
Jan 18, 2022
First Changed:
Mar 23, 2017
Disease(s):
Infection, Bacterial
Intervention(s):
Collection of samplesObiltoxaximab
A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109
Status:
Not yet recruiting
Last Changed:
Jun 24, 2021
First Changed:
Jun 20, 2012
Disease(s):
Anthrax
Intervention(s):
GC1109 or Placebo of GC1109

Connect. Empower. Inspire.